Public filings / CYTK on Yahoo Finance (opens in a new tab)
CYTK: insider buying, 13F holders, analyst moves
Cytokinetics Inc - US
A summary of public filings about Cytokinetics Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
5 of our 100 managers hold CYTK
Combined reported value $755.3M.
Holders among our 100 managers: 2 in Q3 2023, 5 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Avoro Capital Advisors | $425.9M | 3.82% | Added |
| RTW Investments | $243.8M | 2.08% | Added |
| Deep Track Capital | $59.6M | 0.88% | Trimmed |
| Baker Bros. Advisors | $18.0M | 0.09% | New |
| Tudor Investment | $7.9M | 0.03% | New |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.